*To whom correspondence should be addressed. Phone: +49 30 8104 1121. Fax: +49 30 8104 1127. E-mail: [email protected] Article Views are the COUNTER-compliant sum of full text article downloads since ...
POXEL SA (Euronext : POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including metabolic ...
LYON, France--(BUSINESS WIRE)--Regulatory News: POXEL SA (Euronext : POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases ...
Francesca has an MSci in Biochemistry from the University of Birmingham.View full profile Francesca has an MSci in Biochemistry from the University of Birmingham. You wouldn’t think molecules could be ...
The authors note that on page 19168, left column, in the Abstract, line 8, “Here we report its unique comact structure on the basis of four intramolecular thioether bridges with reversed ...
New research presents a versatile method for the synthesis of primary, secondary, and tertiary amines containing two stereogenic centers. In a paper just published at the website of ACS Catalysis, the ...
In a paper just published at the website of ACS Catalysis, the Biocatalysis research group at the University of Amsterdam’s Van ‘t Hoff Institute for Molecular Synthesis presents a versatile method ...
Neuropeptides are cell-to-cell signaling molecules that facilitate communication between neurons, and play important roles in physiology. Some neuropeptides undergo a post-translational modification ...
A presentation will be available after the event on Poxel's website in the Investor section. To register for the webcast in French: https://us02web.zoom.us/webinar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results